C96.Z Other specified malignant neoplasms of lymphoid, hematopoietic and related tissueBillable ICD-10-CM code, FY2026. Acts as a Complication or Comorbidity (CC) as a secondary diagnosis.
Defines the logic of DRG(s) 820-822 in MDC 17.
202.90 Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, unspecified site, extranodal and solid organ sites (approximate)C76 Malignant neoplasm of other and ill-defined sites ("malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)")C77 Secondary and unspecified malignant neoplasm of lymph nodes ("malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)")D59.39 Other hemolytic-uremic syndrome ("malignant neoplasm (C00-C96)")D84.81 Immunodeficiency due to conditions classified elsewhere ("malignant neoplasms (C00-C96)")E08 Diabetes mellitus due to underlying condition ("malignant neoplasm (C00-C96)")Z15.0 Genetic susceptibility to malignant neoplasm (", if applicable, any current malignant neoplasm (C00-C75, C81-C96)")C96.29 Other malignant mast cell neoplasmC96.4 Sarcoma of dendritic cells (accessory cells)C96.5 Multifocal and unisystemic Langerhans-cell histiocytosisC96.6 Unifocal Langerhans-cell histiocytosisC96.A Histiocytic sarcomaC96.Z Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue (this code)C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified